These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 22508707

  • 1. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
    Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Oostdijk W, Bocca G, Mieke Houdijk EC, van Trotsenburg AS, Hoorweg-Nijman JJ, van Wieringen H, Vreuls RC, Jira PE, Schroor EJ, van Pinxteren-Nagler E, Willem Pilon J, Lunshof LB, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2307-14. PubMed ID: 22508707
    [Abstract] [Full Text] [Related]

  • 2. Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
    Donze SH, Damen L, Mahabier EF, Hokken-Koelega ACS.
    Eur J Endocrinol; 2020 Apr; 182(4):405-411. PubMed ID: 31961800
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
    de Lind van Wijngaarden RF, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, van Leeuwen M, Haring DA, Bocca G, Mieke Houdijk EC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3763-71. PubMed ID: 19622627
    [Abstract] [Full Text] [Related]

  • 4. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
    van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [Abstract] [Full Text] [Related]

  • 6. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY, Myers S, Carrel A, Allen D.
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Van Alfen AA, Van Leeuwen M, Van Wieringen H, Wegdam-den Boer ME, Zwaveling-Soonawala N, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.
    Reus L, Pelzer BJ, Otten BJ, Siemensma EP, van Alfen-van der Velden JA, Festen DA, Hokken-Koelega AC, Nijhuis-van der Sanden MW.
    Res Dev Disabil; 2013 Oct; 34(10):3092-103. PubMed ID: 23886754
    [Abstract] [Full Text] [Related]

  • 11. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 12. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA, de Weerd AW, van den Bossche RA, Joosten K, Hoeve H, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF, de Klerk LW, Festen DA, Duivenvoorden HJ, Otten BJ, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1274-80. PubMed ID: 19158197
    [Abstract] [Full Text] [Related]

  • 15. Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial.
    Kuppens RJ, Mahabier EF, Bakker NE, Siemensma EP, Donze SH, Hokken-Koelega AC.
    Orphanet J Rare Dis; 2016 Nov 16; 11(1):153. PubMed ID: 27852283
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA, van Toorenenbergen A, Duivenvoorden HJ, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Apr 16; 92(4):1549-54. PubMed ID: 17264186
    [Abstract] [Full Text] [Related]

  • 17. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.
    Ponjaert-Kristoffersen I, Bonduelle M, Barnes J, Nekkebroeck J, Loft A, Wennerholm UB, Tarlatzis BC, Peters C, Hagberg BS, Berner A, Sutcliffe AG.
    Pediatrics; 2005 Mar 16; 115(3):e283-9. PubMed ID: 15741353
    [Abstract] [Full Text] [Related]

  • 18. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C, Thorén M, Böhm B.
    J Intellect Disabil Res; 2005 Apr 16; 49(Pt 4):245-52. PubMed ID: 15816811
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment.
    de Lind van Wijngaarden RF, Cianflone K, Gao Y, Leunissen RW, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2010 Apr 16; 95(4):1758-66. PubMed ID: 20173020
    [Abstract] [Full Text] [Related]

  • 20. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE, Carrel AL, Whitman BY, Allen DB.
    J Pediatr; 2000 Jul 16; 137(1):42-9. PubMed ID: 10891820
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.